Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model

BACKGROUND: Polymorphonuclear neutrophils, stimulated by the activated complement factor C5a, have been implicated in cardiac ischemia/reperfusion injury. ADC-1004 is a competitive C5a receptor antagonist that has been shown to inhibit complement related neutrophil activation. ADC-1004 shields the n...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: van der Pals, Jesper, Koul, Sasha, Andersson, Patrik, Götberg, Matthias, Ubachs, Joey FA, Kanski, Mikael, Arheden, Håkan, Olivecrona, Göran K, Larsson, Bengt, Erlinge, David
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2010
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2955599/
https://ncbi.nlm.nih.gov/pubmed/20875134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-10-45
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg